Want to see HK:0348 full AI Analyst Report?
China Healthwise Holdings (0348) AI Stock Analysis
China Healthwise Holdings
(HKEX:0348)
The score is held down primarily by weak financial performance, especially negative equity, ongoing operating losses, and declining revenue. Technical indicators are neutral-to-weak with the stock below key longer-term averages and a negative MACD. Valuation provides limited support because earnings are negative and no dividend yield is available.
China Healthwise Holdings (0348) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 56.25M
- Dividend Yield
- ―
- Average Volume (3M)
- 1.80M
- Price to Earnings (P/E)
- -1.7
- Beta (1Y)
- -0.06
- Revenue Growth
- -18.07%
- EPS Growth
- -225.76%
- Country
- Hong Kong
- Employees
- 76
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Leisure
China Healthwise Holdings Business Overview & Revenue Model
Company Description
China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instrument...
China Healthwise Holdings Financial Statement Overview
Summary
Financial strength is weak: revenue is drifting lower and the company remains loss-making with negative operating margins. The most significant risk is the stressed balance sheet with negative shareholder equity and sizable debt relative to assets. Positive operating/free cash flow in 2024–2025 is a partial offset, but the cash generation is small versus leverage and declined in 2025.
Income Statement
24NegativeBalance Sheet
18Very NegativeCash Flow
46Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.20M | 99.56M | 113.58M | 146.32M | 142.06M | 170.08M |
| Gross Profit | 24.79M | 37.20M | 35.00M | 60.29M | 53.27M | 90.99M |
| EBITDA | -27.72M | -6.26M | -13.28M | -117.45M | -45.80M | -89.97M |
| Net Income | -33.12M | -2.61M | -40.28M | -134.56M | -54.27M | -103.05M |
Balance Sheet | ||||||
| Total Assets | 72.56M | 125.21M | 122.05M | 149.67M | 287.66M | 314.10M |
| Cash, Cash Equivalents and Short-Term Investments | 22.69M | 62.62M | 44.72M | 54.28M | 73.02M | 96.91M |
| Total Debt | 94.61M | 106.13M | 103.74M | 108.90M | 109.90M | 90.86M |
| Total Liabilities | 122.66M | 146.20M | 140.43M | 145.27M | 149.01M | 121.03M |
| Stockholders Equity | -50.10M | -38.49M | -18.38M | 4.40M | 138.65M | 193.06M |
Cash Flow | ||||||
| Free Cash Flow | 0 | 2.95M | 3.12M | 14.30M | -28.97M | 41.72M |
| Operating Cash Flow | 3.39M | 3.04M | 3.38M | 14.49M | -28.34M | 42.08M |
| Investing Cash Flow | 5.92M | 5.83M | -257.00K | -191.00K | -631.00K | -360.00K |
| Financing Cash Flow | -4.74M | -9.65M | -7.84M | -17.04M | 5.95M | -36.36M |
China Healthwise Holdings Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0348, the sentiment is Negative. The current price of 0.07 is above the 20-day moving average (MA) of 0.07, above the 50-day MA of 0.07, and below the 200-day MA of 0.09, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 44.21 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0348.
China Healthwise Holdings Peers Comparison
Overall Rating
HK:386954Neutral
HK:151846Neutral- HK:034844Neutral
HK:072242Neutral
HK:213842Neutral
HK:388641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:3869 | 54Neutral | HKD 467.79M | -143.62 | -0.41% | ― | 3.16% | -101.02% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:1518 | 46Neutral | HKD 96.64M | -0.60 | -34.98% | 11.16% | -23.52% | -226.85% |
| HK:0348 | 44Neutral | HKD 67.49M | -1.70 | 82.96% | ― | -18.07% | -225.76% |
| HK:0722 | 42Neutral | HKD 292.35M | -3.79 | -10.76% | 9.04% | -1.37% | -334.69% |
| HK:2138 | 42Neutral | HKD 645.94M | -1.61 | -25.36% | ― | -8.94% | -140.82% |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0348 | China Healthwise Holdings | 0.07 | -0.10 | -57.56% | |
| HK:1518 | New Century Healthcare Holding Co. Ltd. | 0.20 | -0.62 | -75.85% | |
| HK:2138 | EC Healthcare | 0.55 | -0.10 | -16.15% | |
| HK:3869 | Hospital Corporation of China Ltd | 3.38 | -2.61 | -43.49% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:0722 | UMP Healthcare Holdings Limited | 0.36 | -0.07 | -16.67% |
China Healthwise Holdings Corporate Events
China Healthwise Halts Hong Kong Trading Ahead of Takeover-Related Announcement
China Healthwise Holdings Limited has requested a halt in trading of its shares on the Hong Kong Stock Exchange from 9:00 a.m. on 21 September 2026. The suspension comes ahead of an announcement to be issued under Hong Kong’s Code on Takeovers...
China Healthwise Delays Share Consolidation After Trading Halt
China Healthwise Holdings Limited, a Cayman Islands–incorporated company listed in Hong Kong under stock code 348, has disclosed changes affecting its share capital structure to the market. The board, chaired by executive director Lei Hong Wai...
China Healthwise Wins Shareholder Backing for Share Consolidation Effective 22 September 2026
Shareholders of China Healthwise Holdings Limited have approved a share consolidation at an extraordinary general meeting held on 18 September 2026, with the sole resolution gaining 100% of votes cast by poll. All directors attended the meeting, and...
China Healthwise Swings to Interim Loss as Revenue Falls
China Healthwise Holdings reported a sharp deterioration in its unaudited interim results for the six months ended 30 June 2026, with revenue falling to HK$36.5 million from HK$51.1 million a year earlier and gross profit dropping to HK$4.8 million....
China Healthwise Completes HK$10.8 Million Share Subscription to Fund Operations and Debt Interest
China Healthwise Holdings Limited has completed a subscription of 154.09 million new shares under its general mandate, representing about 16.7% of its enlarged share capital, at HK$0.07 per share. The transaction, completed on 27 August 2026, introdu...
China Healthwise Calls EGM to Approve Share Consolidation Plan
China Healthwise Holdings Limited has called an extraordinary general meeting in Hong Kong on 18 September 2026 to seek shareholder approval for a proposed share consolidation. The move, conducted under Hong Kong listing rules and overseen via poll v...
China Healthwise warns of interim loss on financial instrument and loan impacts
China Healthwise Holdings has issued an inside information announcement warning that it expects to swing to a loss attributable to shareholders of about HK$28 million to HK$30 million for the six months ended 30 June 2026, compared with a profit of r...
China Healthwise Sets August Board Meeting to Review Interim Results and Dividend
China Healthwise Holdings Limited has scheduled a board meeting for 27 August 2026 to review the unaudited interim results for the six months ended 30 June 2026. The meeting will also consider whether to declare an interim dividend and address other...
China Healthwise Proposes 5-for-1 Share Consolidation Ahead of 2026 Vote
China Healthwise Holdings Limited plans to consolidate every five existing shares of HK$0.01 par value into one consolidated share of HK$0.05, reducing its issued share count from 770,480,836 to 154,096,167 while keeping authorised share capital unch...
China Healthwise to Raise HK$10.8 Million via Premium Share Subscription
China Healthwise Holdings has agreed to issue 154,090,000 new shares to an independent merchant subscriber at HK$0.07 per share, representing about 20% of its existing share capital. The subscription price carries a roughly 16.7% premium to the recen...
China Healthwise Shareholders Unanimously Approve All AGM Resolutions
China Healthwise Holdings reported that all resolutions at its 25 June 2026 annual general meeting were approved by shareholders via poll, including receipt of the 2025 audited accounts, re-election of two executive and two independent non-executive...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 24, 2026